Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
СпутникиРНSpaceXРоскосмосNASAThis Viewpoint discusses the US Centers for Medicare & Medicaid Services’ (CMS) extension of the Medicare Glucagon-Like Peptide-1 (GLP-1) Bridge and outlines unanswered questions related to how the bridge will affect Medicare.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | 7 things to know about Medicare's new GLP-1 coverage | 0 | 7 | 02-07-2026 |
| 2 | Who qualifies for Medicare's new $50-a-month GLP-1 program? | 0 | 7.35 | 24-10-2026 |
| 3 | Who qualifies for Medicare's new $50-a-month GLP-1 program? | 0 | 7.35 | 24-10-2026 |
| 4 | Who qualifies for Medicare's new $50-a-month GLP-1 program? | 0 | 7.35 | 24-10-2026 |
| 5 | Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know | 5 | 7 | 01-07-2026 |
| 6 | GLP-1 insurance change impacts millions of Americans: What to know, how to tell if you're covered | 0 | 7 | 19-07-2026 |
| 7 | GLP-1 drugs could reduce long-term sick leave: Study | 0 | 18.9 | 26-07-2026 |
| 8 | GLP-1 drugs could reduce long-term sick leave: Study | 0 | 18.9 | 26-07-2026 |
| 9 | Bridging the Information Gap: How Organizations Can Assess and Use Benefits Screeners | 0 | 5 | 01-07-2026 |
| 10 | Ohio study finds GLP-1s are reshaping restaurant habits, with users spending less | 0 | 5.45 | 24-07-2026 |